Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Shares Gap Up - Here's Why

Key Points

• SGIOY shares initially gapped higher, opening at $9.73 versus a prior close of $9.26, but later traded at $9.01, down 2.7%, on light volume of 704 shares.
• Analyst sentiment has improved: Goldman Sachs and Jefferies upgraded the ADR to “strong buy,” while Zacks Research moved it to “hold.” The stock carries an overall “Buy” rating based on two Strong Buy and one Hold recommendation.
• Shionogi beat quarterly expectations, reporting $0.36 in EPS versus the $0.18 consensus and revenue of $1.04 billion versus estimates of $970.69 million. The company posted a 46.67% net margin and analysts expect $0.82 in full-year EPS.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report)'s stock price gapped up prior to trading on Friday . The stock had previously closed at $9.26, but opened at $9.73. Shionogi & Co., Ltd. Unsponsored ADR shares last traded at $9.01, with a volume of 704 shares changing hands.

Wall Street Analyst Weigh In

SGIOY has been the subject of several recent analyst reports. Zacks Research upgraded shares of Shionogi & Co., Ltd. Unsponsored ADR from a "strong sell" rating to a "hold" rating in a research report on Monday, May 25th. The Goldman Sachs Group upgraded Shionogi & Co., Ltd. Unsponsored ADR from a "hold" rating to a "strong-buy" rating in a research report on Monday, June 15th. Finally, Jefferies Financial Group raised Shionogi & Co., Ltd. Unsponsored ADR from a "hold" rating to a "strong-buy" rating in a report on Tuesday, July 14th. Two investment analysts have rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Buy".

Shionogi & Co., Ltd. Unsponsored ADR Trading Down 2.7%

The firm has a market capitalization of $15.83 billion, a P/E ratio of 9.30, a PEG ratio of 3.32 and a beta of 0.08. The business's 50 day moving average is $9.02 and its two-hundred day moving average is $9.52. The company has a quick ratio of 1.00, a current ratio of 1.14 and a debt-to-equity ratio of 0.01.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) last announced its earnings results on Monday, August 3rd. The company reported $0.36 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.18 by $0.18. Shionogi & Co., Ltd. Unsponsored ADR had a net margin of 46.67% and a return on equity of 16.13%. The firm had revenue of $1.04 billion during the quarter, compared to analyst estimates of $970.69 million. Analysts expect that Shionogi & Co., Ltd. Unsponsored ADR will post 0.82 EPS for the current year.

Shionogi & Co., Ltd. Unsponsored ADR Company Profile

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that researches, develops, manufactures and markets prescription medicines. Founded in Osaka in 1878, the company has built its business around drug discovery and has a particular focus on infectious diseases, including antiviral and antibacterial treatments.

Shionogi's products include Xofluza (baloxavir marboxil), an oral treatment for influenza, and Fetcroja (cefiderocol), an antibiotic used for certain difficult-to-treat bacterial infections.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.